Acne - a modern view on the problem
- Authors: Kochetkov M.A1,2, Gryazeva N.V1,2, Kolody A.A1,2
-
Affiliations:
- Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology
- Central State Medical Academy
- Issue: Vol 26, No 8 (2019)
- Pages: 59-66
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312448
- DOI: https://doi.org/10.18565/pharmateca.2019.8.59-67
- ID: 312448
Cite item
Open Access
Access granted
Abstract
The article provides an overview of current trends in etiology, pathogenesis, approaches to the treatment of acne. Acne is considered a chronic non-infectious disease, with inflammation as an underlying pathogenesis. Acne affects up to 85% of the population. Currently, approaches to the management of patients with this disease are changed. So, one of the main Global Acne Alliance recommendations includes avoiding the use of topical and systemic antibiotics as monotherapy. Retinoids are still the drug of choice in the treatment of acne.
Keywords
Full Text
About the authors
M. A Kochetkov
Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology; Central State Medical Academy
N. V Gryazeva
Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology; Central State Medical Academy
Email: tynrik@yandex.ru
A. A Kolody
Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology; Central State Medical Academy
References
- Gollnick H. Acne and related disorders. In: Elzouki A.Y., Harfi H.A, Nazer H, Oh W, Stapleton F.B., Whitley R.J., eds. Textbook of Clinical Pediatrics. Berlin: Springer, 2012. Р 1447-66.
- Gollnick H.P, Bettoll V, Lambert J, et al. A consensus-based practical and daily guide for the treatment of acne patients. J Eur Acad Dermatol Venereol. 2016;30(9):1480-90. Doi: 10.1111/ jdv. 13675.
- Del Rosso J.Q. Management of truncal acne vulgaris: current perspectives on treatment. Cutis. 2006;77:277-89.
- Abad-Caslntahan F., Chow S.K., Goh C.L., et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826-28. doi: 10.1111/13468138.13263.
- Tan J., Kang S., Leyden J. Prevalence and risk factors of acne scarring among patients consulting dermatologists in the Unites States. J Drugs Dermatol. 2017;16:97-102.
- Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половым путем (рабочая группа по ведению больных с акне: Аравийская Е.А., Самцов А.В.). 5-е изд., перераб. и доп. М.: Деловой экспресс, 2016
- Zaenglein A.L., Pathy A.L., Schlosser B.J., et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945- 73. e33. doi: 10.1016/j.jaad.2015.12.037.
- Dreno B, Thiboutot D, Gollnick F.I., et al. Antibiotic stewardship in dermatology: limiting antibiotic use in acne. Eur J Dermatol. 2014;24:330-34.
- Thiboutot D, Dreno B, Gollnick F.I., et al. A call to limit antibiotic use in acne. J Drugs Dermatol.: JDD. 2013;12:1331-32.
- World Health Organization. The evolving threat of antimicrobial resistance-options for action. Geneva: WFIO, 2012. URL: https://apps.who.int/ iris/bitstream/handle/10665/44812/97892?seq uence=1
- Bikowski J.B. Subantimicrobial dose doxycydine for acne and rosacea. Skinmed. 2003;2:234-45. doi: 10.1111/j.1540-9740.2003.03014.x.
- Nast A, Dreno B, Bettoli V, et al. European Evidence-based (S3) Guidelines for the Treatment of Acne. JEADV. 2016;30(8):1261-68. doi: 10.1111/jdv. 13776.
- Layton A.M., Henderson C.A, Cunliffe W.J. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol. 1994;9:303-8. doi: 10.1111/j.1365-2230.1994.tb01200.x.
- Layton A.M., Seukeran D, Cunliffe W.J. Scarred for life? Dermatol. 1997;195(Suppl. 1):15-21; discussion 38-40. doi: 10.1159/000246015.
Supplementary files
